Three Cases of Recalcitrant Pediatric Tinea Capitis Successfully Treated with Griseofulvin
- Author:
Eui-Sung JUNG
1
;
Sang-Kyung LEE
;
Il-Jae LEE
;
Kyung-Hwa NAM
;
Seok-Kweon YUN
;
Han-Uk KIM
;
Jin PARK
Author Information
- Publication Type:Case Report
- From:Annals of Dermatology 2023;35(Suppl2):S247-S251
- CountryRepublic of Korea
- Language:English
- Abstract: Tinea capitis is an infection of the scalp hair follicles and surrounding skin that primarily occurs in prepubertal children. Microsporum canis remains the most common pathogen causing tinea capitis in Asian countries, including South Korea, although the causative organism of this condition varies across geographical regions and time periods. Systemic antifungal agents are the mainstay treatments for tinea capitis; however, the therapeutic responses to antifungal drugs may vary depending on the causative species, and treatment failure may occur owing to drug resistance. Although dermatophytosis resistant to clinical treatment have been increasingly encountered, recalcitrant tinea capitis cases have rarely been reported. Herein, we report three cases of tinea capitis caused by M. canis in children. All three patients showed unsatisfactory clinical responses to prolonged courses of oral terbinafine or itraconazole without achieving mycological cure; however, they were successfully treated with oral griseofulvin. Although griseofulvin is not currently available or licensed for use in many countries, including South Korea, it is one of the most effective agents against Microsporum species and remains the most widely used first-line treatment for tinea capitis in children, based on dermatology textbooks and reliable treatment guidelines.
